Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:11 PM ET 8-K
Financial Results LifeMD, Inc. LFMD

LifeMD Financial Results

LifeMD reported Q3 2026 revenue of $44.6 million and a GAAP net loss of $5.2 million, while improving adjusted EBITDA sequentially by $3.1 million. The company also announced it secured a $12.5 million senior secured term loan from Avenue Venture Opportunities Fund II and Avenue Growth Lending Fund to replace its previous credit facility.

Term
Q3 2026

“We ended the quarter with approximately 350,000 active subscribers, up 13% from a year ago and nearly flat from the second quarter, despite spending $9.5 million less on marketing. We’re helping more people access high-quality healthcare, and we’re getting more efficient at doing it. From May to September, cost per acquisition fell 32% while monthly media spend declined 45%. Adjusted EBITDA improved approximately $3.1 million sequentially to roughly breakeven, and we expect to sustain or improve these unit economics going forward.”

Justin Schreiber, Chairman and CEO of LifeMD

“Revenue of $44.6 million was below our guidance, and we are resetting our outlook for the fourth quarter and full year. We deliberately reduced marketing spend and prioritized longer patient commitments, and our partnerships took longer to ramp than we expected. Those factors weighed on revenue this quarter, but we believe our decisions put us in a stronger position to grow profitably.”

Justin Schreiber, Chairman and CEO of LifeMD
4:11 PM ET 8-K
Financial Results Ascend Wellness Holdings, Inc. AAWH

Ascend Wellness Holdings Financial Results

Ascend Wellness Holdings reported Q3 2026 net revenue of $130.0 million, a 4.2% year-over-year increase, driven by record retail transaction volumes. The company generated $31.1 million in Adjusted EBITDA and ended the quarter with 56 retail stores, subsequently expanding to 61 locations. Management highlighted strong operating leverage and positive cash flow from operations despite a significant semi-annual interest payment.

Term
Q3 2026

“Our third quarter results demonstrate the strength of our retail platform and the growing demand for our brands. We achieved record transaction volume and expanded our footprint ahead of schedule, positioning Ascend for continued growth as we optimize our operations and prepare for potential regulatory shifts in the industry.”

John Redman, CEO
4:11 PM ET 10-Q
Financial Results Hour Loop, Inc HOUR

Hour Loop Q3 2026 Results: Net Income $422K, Down 20.5% YoY

Hour Loop, Inc. reported net income of $2.30 million for the nine months ended September 30, 2026, on revenues of $95.95 million, representing an 11% revenue increase year-over-year. Despite higher sales, net income slightly decreased from $2.36 million in the prior year period due to increased cost of revenues and selling expenses.

Key figure
Net income $422K · -20.5% YoY
4:11 PM ET 8-K
Financial Results Relmada Therapeutics, Inc. RLMD

Relmada Therapeutics Financial Results

Relmada Therapeutics reported third quarter 2026 financial results and provided a corporate update on its NDV-01 and sepranolone programs. The company ended the quarter with $202.1 million in cash, which is expected to fund operations through 2029, and remains on track to submit an IND for NDV-01 by year-end 2026.

“Relmada has made significant progress in advancing the NDV-01 CMC program and remains on track to submit the NDV-01 IND by year-end 2026. Furthermore, we have established a manufacturing plan to provide uninterrupted clinical supply through the completion of the Phase 3 SPECTRUM program.”

Sergio Traversa, Chief Executive Officer of Relmada Therapeutics

“Initial 18-month results from the ongoing NDV-01 Phase 2 study demonstrate extended durability of complete response and continued favorable tolerability. Our Phase 3 program remains unchanged, with two independent registrational pathways in NMIBC, and we have renamed it SPECTRUM to reflect the potential breadth of NDV-01 across the NMIBC disease spectrum. We expect to begin the SPECTRUM program upon IND clearance.”

Bipin Dalmia, Chief Business Officer of Relmada Therapeutics
4:11 PM ET 8-K
Financial Results OptimumBank Holdings, Inc. OPHC

OptimumBank Holdings Financial Results

OptimumBank Holdings reported Q3 2026 net income of $7.2 million, or $0.30 per diluted share, representing a 67% increase in EPS compared to the prior year. The company saw strong balance sheet growth with the gross loan portfolio increasing 12.3% sequentially to $1.37 billion and total deposits rising 10.6% to $1.34 billion.

Term
Q3 2026
4:11 PM ET 8-K
Financial Results Fluent, Inc. FLNT

Fluent Financial Results

Fluent, Inc. reported Q3 2026 revenue of $53.6 million, a 14% increase year-over-year, driven by a 100% growth in its Commerce Media Solutions segment. The company significantly reduced its net loss to $3.1 million from $7.6 million in the prior year and achieved breakeven Adjusted EBITDA.

Term
Q3 2026

“The third quarter was another strong quarter for us, driven by the continued growth of Commerce Media Solutions, which now represents 70% of our revenue and is operating at an annual revenue run rate that exceeds $145 million. Revenue from our aggregate continuing businesses grew 29% year-over-year in the third quarter, an acceleration from 25% in the second quarter. Commerce Media Solutions continues to reshape the profile of our Company. It is driving our growth, improving the quality of our revenue, and was a key contributor to delivering near-breakeven adjusted EBITDA this quarter.”

Don Patrick, Chief Executive Officer

“We continue to add new partners to our network, and we’re highly encouraged by the demand we’re seeing for our commerce media offerings across the markets we serve. As our revenue mix improves and our margin profile strengthens, we believe we are well positioned to close out a strong year. We remain confident in delivering full-year double-digit revenue growth on our aggregate continuing businesses with improved full-year adjusted EBITDA.”

Don Patrick, Chief Executive Officer
4:11 PM ET 8-K
Financial Results GrabAGun Digital Holdings Inc. PEW

GrabAGun Digital Holdings Financial Results

GrabAGun Digital Holdings reported Q3 2026 net revenues of $21.2 million, a 4.7% decrease year-over-year due to lower product sales. Despite the revenue dip, gross profit increased 44% and gross margin expanded 480 basis points to 14.4%, driven by improved sourcing and disciplined purchasing.

Term
Q3 2026

“Our third-quarter results reflect the progress we are making in improving the quality and profitability of our business. Gross profit increased 44% and gross margin expanded 480 basis points to 14.4%, primarily driven by average selling prices and supported by better sourcing, a stronger product cost basis and disciplined purchasing.”

Marc Nemati, Chairman and Chief Executive Officer

“Subsequent to quarter end, we completed the acquisition of Camfour, a New England-based wholesale distributor funded entirely with cash on hand and without financing or issuing shares. We believe combining Camfour's distribution capabilities with our e-commerce and logistics platform will stimulate growth, expand our customer base and improve our purchasing economics.”

Marc Nemati, Chairman and Chief Executive Officer
4:11 PM ET 8-K
Financial Results United States Antimony Corp UAMY

United States Antimony Financial Results

United States Antimony Corp reported Q3 2026 revenue of $10.1 million, a 16% increase year-over-year, driven by a 68% surge in antimony pounds sold. Despite a 113% increase in gross profit to $4.3 million, the company reported a net loss of $9.5 million, impacted by non-cash stock-based compensation and an unrealized loss on its Larvotto Resources investment.

Term
Q3 2026
4:11 PM ET 8-K
Financial Results Equillium, Inc. EQ

Equillium Financial Results

Equillium reported third quarter 2026 financial results, highlighting the initiation of a Phase 1 clinical trial for EQ504 with proof-of-mechanism data expected in Q2 2027. The company strengthened its balance sheet with a $20 million financing tranche closed in October 2026, extending its cash runway into 2029.

“We continue to make important progress advancing EQ504, with the recent initiation of clinical development marking a significant milestone for the program. We believe EQ504’s differentiated immunoregulatory mechanism of action, without broad immune suppression, has the potential to address key epithelial and immune pathways involved in inflammatory disease.”

Bruce Steel, Chief Executive Officer of Equillium

“We look forward to reporting proof-of-mechanism data in the second quarter of 2027, which we expect will inform our planned proof-of-concept study in ulcerative colitis that we expect to initiate in the second half of 2027. Supported by our strong financial position, we remain focused on advancing EQ504 to patients while continuing to evaluate its broader therapeutic potential.”

Bruce Steel, Chief Executive Officer of Equillium
4:11 PM ET 8-K
Financial Results Sanara MedTech Inc. SMTI

Sanara MedTech Financial Results

Sanara MedTech reported Q3 2026 net revenue of $28.4 million, an 8% increase year-over-year, and Adjusted EBITDA of $5.6 million. The company recorded a net loss from continuing operations of $1.3 million, which included $3.0 million in legal and advisory costs related to its pending merger with MiMedx Group, Inc.

Term
Q3 2026
4:11 PM ET 10-Q
Financial Results Pliant Therapeutics, Inc. PLRX

Pliant Therapeutics Q3 2026 Results: Net Loss of $24.4M, Loss Narrows

Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on integrin-based therapeutics, with its lead candidate PLN-101095 currently in Phase 1a/1b trials. The company reports significant net losses since inception and expects to require substantial additional capital to fund its ongoing research and development activities.

Key figure
Net loss $24.4M
4:11 PM ET 10-Q
Financial Results Rhinebeck Bancorp, Inc. RBKB

Rhinebeck Bancorp Q3 2026 Results: Net Income $3.15M, Up 17.0% YoY

Rhinebeck Bancorp, Inc. reported net income of $3.15 million for the quarter ended September 30, 2026, compared to $2.70 million in the prior year period. The company completed its conversion to a fully public company on July 21, 2026, resulting in a significant increase in total stockholders' equity to $220.8 million.

Key figure
Net income $3.15M · +17.0% YoY
4:11 PM ET 10-Q
Financial Results Socket Mobile, Inc. SCKT

Socket Mobile Q3 2026 Results: Net Loss of $789K, Loss Narrows

Socket Mobile reported a 9% increase in Q3 2026 revenue to $3.39 million, though year-to-date revenue remains down 8.9% compared to 2025. The company continues to operate at a loss, reporting a net loss of $0.79 million for the quarter and $3.04 million for the first nine months of 2026, as it manages high operating expenses relative to gross profit.

Key figure
Net loss $789K
4:11 PM ET 8-K
Financial Results Eledon Pharmaceuticals, Inc. ELDN

Eledon Pharmaceuticals Financial Results

Eledon Pharmaceuticals reported third quarter 2026 financial results, highlighting a cash position of $69.7 million and progress in its tegoprubart clinical program. The company remains on track to initiate its global Phase 3 LEGACY trial in kidney transplantation in Q4 2026 and recently received FDA Fast Track designation for the candidate.

Term
Q3 2026

“We continue to execute across our key strategic priorities and make meaningful progress in the tegoprubart clinical program across multiple transplant types, including plans to initiate our global Phase 3 LEGACY trial in kidney transplantation by year end.”

David-Alexandre C. Gros, M.D., Chief Executive Officer
4:10 PM ET 10-Q
Financial Results Fossil Group, Inc. FOSL

Fossil Group Q3 2026 Results: Turns Profitable, Net Income $11.4M

For the 13 weeks ended October 3, 2026, Fossil Group reported net sales of $271.2 million and net income attributable to the company of $11.7 million, a significant recovery from the $39.9 million loss in the prior year period. For the 39-week period, the company achieved a narrow net income of $0.2 million compared to a $59.7 million loss in 2025, driven by improved gross margins and reduced operating expenses.

Key figure
Net income $11.4M
4:10 PM ET 10-Q
Financial Results Shimmick Corp SHIM

Shimmick Q3 2026 Results: Turns Profitable, Net Income $848K

Shimmick Corporation reported a net income of $0.8 million for the third quarter of 2026, a significant improvement from a $4.4 million loss in the prior year period, despite a slight decrease in revenue to $135.8 million. For the nine months ended October 2, 2026, the company reduced its net loss to $8.4 million compared to $22.5 million in 2025, driven by improved gross margins and equity in earnings from joint ventures.

Key figure
Net income $848K
4:10 PM ET 8-K
Financial Results Arcadia Biosciences, Inc. RKDA

Arcadia Biosciences Financial Results

Arcadia Biosciences reported third-quarter 2026 financial results, highlighted by a 24% year-over-year increase in total revenues to $1.6 million. The growth was primarily driven by record quarterly sales for the Zola coconut water brand, which benefited from strong summer promotional programs and expanded distribution.

Term
Q3 2026

“The third quarter was very strong for Zola® with revenues growing 24% compared to the same quarter last year, resulting in the highest quarterly sales the brand has ever reported.”

T.J. Schaefer, CEO of Arcadia

“We are extremely excited to begin shipping our newly formulated espresso flavor this month after receiving pre-launch commitments from several of our leading customers.”

T.J. Schaefer, CEO of Arcadia
4:10 PM ET 10-Q
Financial Results Binah Capital Group, Inc. BCG

Binah Capital Group Q3 2026 Results: Net Income $2.65M, Up 50.3% YoY

Binah Capital Group reported a significant increase in net income to $4.89 million for the nine months ended September 30, 2026, compared to $2.14 million in the prior year period. Total revenues grew to $145.8 million, driven primarily by higher commission and advisory fee income, while the company maintained a strong cash position of $13.2 million.

Key figure
Net income $2.65M · +50.3% YoY
4:10 PM ET 10-Q
Financial Results Middleby Corp MIDD

Middleby Q3 2026 Results: Net Loss of $1.61M, Loss Narrows

Middleby Corp reported net sales of $1.90 billion for the first nine months of 2026, up from $1.75 billion in the prior year, though net earnings were significantly impacted by a $129.1 million loss from discontinued operations. The company completed the Midera spin-off during the period, resulting in a $780.2 million reduction in stockholders' equity.

Key figure
Net loss $1.61M
4:10 PM ET 10-Q
Financial Results Sunshine Silver Mining & Refining Co SSMR

Sunshine Silver Mining & Refining Q3 2026 Results: Net Loss of $20.9M, Loss Widens

Sunshine Silver Mining & Refining Company completed its IPO in June 2026, raising $291.9 million in net proceeds, significantly strengthening its cash position to $261.4 million. The company reported a net loss of $50.9 million for the nine months ended September 30, 2026, driven primarily by increased pre-development and general administrative expenses as it scales operations.

Key figure
Net loss $20.9M
4:10 PM ET 10-Q
Financial Results TriplePoint Private Venture Credit Inc.

TriplePoint Private Venture Credit Q3 2026 Results: Net Income $20.2M, Up 577.6% YoY

TriplePoint Private Venture Credit Inc. reported a significant turnaround for the nine months ended September 30, 2026, with a net increase in net assets resulting from operations of $39.5 million compared to a $3.0 million loss in the prior year period. This improvement was primarily driven by $34.2 million in net change in unrealized gains on investments, despite a slight decrease in total investment income.

Key figure
Net income $20.2M · +577.6% YoY
4:10 PM ET 10-Q
Financial Results Northpointe Bancshares Inc NPB

Northpointe Bancshares Q3 2026 Results: Net Income $14.4M, Down 35.2% YoY

Northpointe Bancshares Inc. is an emerging growth company that operates as a non-accelerated filer. The filing highlights risks related to the mortgage banking sector, including the proposed sale of its distributed retail and consumer direct mortgage origination channels and the impact of prolonged elevated interest rates on loan demand and liquidity.

Key figure
Net income $14.4M · -35.2% YoY
4:10 PM ET 10-Q
Financial Results Virgin Galactic Holdings, Inc SPCE ▶ Call

Virgin Galactic Holdings Q3 2026 Results: Net Loss of $58.8M, Loss Narrows

Virgin Galactic reported a net loss of $58.8 million for the third quarter of 2026, an improvement from the $64.4 million loss in the prior year period. The company is focused on developing its next-generation Delta Class vehicles while managing a significant reduction in research and development expenses as it transitions through its flight fleet development phases.

Key figure
Net loss $58.8M
4:10 PM ET 10-Q
Financial Results Andersen Group Inc. ANDG ▶ Call

Andersen Group Q3 2026 Results: Net Loss of $8.98M

Andersen Group Inc. reported total assets of $758.7 million as of September 30, 2026, a significant increase from $565.1 million at year-end 2025, driven largely by higher accounts receivable and the recognition of deferred tax assets. The company maintains a dual-class stock structure and reported an accumulated deficit of $790.5 million, reflecting ongoing investments in scaling its AI-driven service offerings and business expansion.

Key figure
Net loss $8.98M
4:10 PM ET 10-Q
Financial Results Brookfield Private Equity Fund LP

Brookfield Private Equity Fund Q3 2026 Results: Turns Profitable, Net Income $26.1M

Brookfield Private Equity Fund LP is a non-accelerated filer and emerging growth company that reported various unit classes outstanding as of October 31, 2026, including 24.6 million Class B-1 units. Effective September 1, 2026, the fund ceased offering Class D units, focusing its non-Brookfield investor offerings on Class I and Class S units.

Key figure
Net income $26.1M
4:09 PM ET 8-K
Financial Results Accelevation Holdings Corp. ACCV

Accelevation Holdings Financial Results

Accelevation Holdings Corp. reported its first quarterly results as a public company, with revenue growing 66% year-over-year to $202.2 million. The company saw significant demand with bookings of $768.9 million and a backlog reaching $1.7 billion, driven by mission-critical infrastructure needs.

Term
Q3 2026

“At Accelevation, we design, manufacture, and install mission-critical infrastructure for customers who rely on our speed and certainty of delivery, and our third quarter results reflect the strength of our operating model and underlying markets.”

Michael Rubiera, Co-Founder and Chief Executive Officer

“We delivered strong growth, profitability, and cash generation in the quarter. Revenue increased more than 60%, bookings grew more than 350%, backlog rose to approximately $1.7 billion, and Adjusted EBITDA margins approached 19% following a weaker first half.”

Ken Krause, Chief Financial Officer
4:09 PM ET 8-K
Financial Results Intellicheck, Inc. IDN

Intellicheck Financial Results

Intellicheck reported its third quarter 2026 financial results, achieving its fifth consecutive quarter of profitability with net income of $0.5 million. Despite a 5% year-over-year revenue decline to $5.7 million, the company grew its cash balance to $13.2 million and maintained a strong 91% gross margin. Management highlighted expansion into new verticals like wealth management and freight logistics to combat rising synthetic identity fraud.

Term
Q3 2026

“We delivered our fifth consecutive quarter of profitability and sixth consecutive quarter of positive Adjusted EBITDA in Q3 2026, with both net income and Adjusted EBITDA up year-over-year, demonstrating the strength and durability of our business model.”

Bryan Lewis, President and Chief Executive Officer

“We remain profitable and cash from operations came in ahead of what we anticipated last quarter. Cash rose $1.3 million in the quarter to $13.2 million, our highest quarter-end level since the end of 2021, and we have no debt.”

Adam Sragovicz, Chief Financial Officer
4:09 PM ET 8-K
Financial Results NeuroPace Inc NPCE

NeuroPace Financial Results

NeuroPace reported Q3 2026 total revenue of $23.1 million, missing internal expectations due to commercial execution issues and field organization disruption. The company revised its full-year 2026 revenue guidance downward to $91-$92 million while advancing its innovation pipeline, including an FDA submission for NeuroPace Remote Care.

Term
Q3 2026

“Third-quarter revenue was below our expectations, and we have taken and are taking action to improve commercial execution and return the business to historical growth rates. The shortfall was concentrated in several of our largest accounts and reflected isolated account-level issues and changes to our field organization that created more disruption than anticipated.”

Joel Becker, President and Chief Executive Officer of NeuroPace

“Our innovation pipeline represents one of the most significant opportunities ahead for NeuroPace, combining potential indication expansion with capabilities that can make RNS therapy more accessible, efficient and personalized.”

Joel Becker, President and Chief Executive Officer of NeuroPace
4:09 PM ET 8-K
Financial Results Shimmick Corp SHIM

Shimmick Financial Results

Shimmick Corp reported Q3 2026 financial results, achieving its first quarter of positive net income since Q3 2023. Revenue for the quarter was $136 million, driven by a 28% year-over-year increase in Shimmick Projects as the company transitions away from legacy non-core work.

Term
Q3 2026

“Third quarter results show our strategy working. We returned to positive net income for the first time since the third quarter of 2023, and Shimmick Projects revenue grew 28% year over year as newer, higher-margin work replaced legacy projects. We are winning the projects we want, in the markets we want, at the risk profile we want. With strong demand in water and electrical infrastructure and a backlog that is increasingly diversified across markets, funding sources and customers, we expect to continue growing revenue and earnings from here.”

Ural Yal, Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.